Back to Top

There is a Mary Ann Liebert at Mary Ann Liebert, Inc. and that makes a difference.

For Immediate Release

Six Lessons Learned from South Korea’s Successful COVID-19 Vaccine Roll Out

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, September 21, 2022—South Korea had administered more COVID-19 vaccine doses per 100 people than other developed countries by the end of March 2022. A new article published in the peer-reviewed OMICS: A Journal of Integrative Biology presents six pivotal lessons learned from South Korea’s whole-of-government approach to successful COVID-19 vaccine roll out. Click here to read the article now.

“The COVID-19 pandemic has underscored that systems medicine depends on health systems and services that can respond to planetary health threats in scale and with speed,” states author Shin Ae Hong, PhD, from Sungkyunkwan University, South Korea. Dr. Hong provides an overview of Korea’s pandemic response and identifies and provides a detailed description of six factors that account for Korea’s robust national vaccination initiative: governance system; logistic capability; delivery strategy and accessibility; public health infrastructure; risk communication; and public cooperation and engagement.

“The lessons from South Korea can help cultivate planetary health action in other parts of the world during the current COVID-19 pandemic, and in ecological crises in the future,” says Dr. Hong.

“Vaccine rollout and its governance are as important as vaccine discovery and development. The study makes an important contribution by unpacking the multiple determinants of COVID-19 vaccine rollout in South Korea, and from the vaccine factory to the public health clinic. Therefore, the paper has relevance for a very wide range of readers interested in vaccine discovery and development, engineering, manufacturing, systems medicine and public health. The findings inform global governance for science, technology and innovation in the current era of COVID-19 and ecological crises. I invite new manuscripts on large-scale biology, ecology, and critical governance of vaccines and other planetary health interventions for peer review in the journal,” says Vural Özdemir, MD, PhD, DABCP, Editor-in-Chief of OMICS.

About the Journal

OMICS: A Journal of Integrative Biology is an authoritative and highly innovative peer-reviewed interdisciplinary journal published monthly online, addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of the large-scale biology and 21st century data-enabled sciences are also peer-reviewed. Complete tables of content and a sample issue may be viewed on the OMICS: A Journal of Integrative Biology website.
 
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s more than 100 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com